Listed

Roper Technologies Inc

ROPNasdaqCIK 882835TechnologyFiscal year ends Dec 31

Reports and events: 267 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Roper Technologies Inc, Reports and events
FiledFormWhat it isAccession number
2022-12-1516:35 ET8-K/A5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000882835-22-000079
2022-11-2216:32 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0000882835-22-000076
2022-11-1508:45 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-285317
2022-11-0209:04 ET10-QQuarterly reportPeriod 2022-09-300000882835-22-000072
2022-10-2607:28 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-22-000066
2022-10-0411:00 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0000882835-22-000063
2022-08-3011:16 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-233743
2022-08-0316:39 ET10-QQuarterly reportPeriod 2022-06-300000882835-22-000060
2022-07-2208:58 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-22-199694
2022-07-2207:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-22-000056
2022-06-3007:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000882835-22-000052
2022-06-2316:44 ET8-K8.01 Other events0000882835-22-000045
2022-06-1716:11 ET8-K5.07 Shareholder vote results0000882835-22-000043
2022-06-0109:10 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-164703
2022-05-0408:14 ET10-QQuarterly reportPeriod 2022-03-310000882835-22-000025
2022-04-2916:01 ETDEF 14AProxy statementPeriod 2022-06-150001193125-22-133523
2022-04-2607:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-22-000021
2022-03-1807:00 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0000882835-22-000017
2022-03-1717:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000882835-22-000016
2022-02-2217:02 ET10-KAnnual reportPeriod 2021-12-310000882835-22-000012
2022-02-0207:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-22-000005
2021-11-0408:39 ET10-QQuarterly reportPeriod 2021-09-300000882835-21-000067
2021-10-2207:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000882835-21-000058
2021-10-2207:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-21-000057
2021-10-0816:17 ET8-K8.01 Other events0000882835-21-000050
2021-10-0408:16 ET8-K1.01 Entry into a material agreement0000882835-21-000048
2021-08-0509:03 ET10-QQuarterly reportPeriod 2021-06-300000882835-21-000044
2021-07-2307:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-21-000039
2021-06-1414:00 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-21-189824
2021-05-0509:15 ET10-QQuarterly reportPeriod 2021-03-310000882835-21-000018
2021-04-2916:05 ETDEF 14AProxy statementPeriod 2021-06-140001193125-21-140367
2021-04-2707:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-21-000016
2021-03-2208:47 ET8-K5.02 Departure or appointment of officers or directors0000882835-21-000014
2021-02-2208:59 ET10-KAnnual reportPeriod 2020-12-310000882835-21-000011
2021-01-2907:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-21-000009
2021-01-0615:59 ET8-K5.02 Departure or appointment of officers or directors0000882835-21-000004
2020-11-0414:55 ET10-QQuarterly reportPeriod 2020-09-300000882835-20-000033
2020-10-2707:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-20-000030
2020-10-0916:07 ET8-K8.01 Other events0000882835-20-000026
2020-09-0311:51 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-238787
2020-09-0110:29 ET8-K2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-236871
2020-08-1917:39 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-223751
2020-08-1312:56 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-218831
2020-08-0511:36 ET10-QQuarterly reportPeriod 2020-06-300000882835-20-000025
2020-07-2807:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000882835-20-000022
2020-06-2210:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-174903
2020-06-1016:31 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-20-165722
2020-05-0613:26 ET10-QQuarterly reportPeriod 2020-03-310000882835-20-000012
2020-04-2807:06 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0000882835-20-000009
2020-04-2415:11 ETDEF 14AProxy statementPeriod 2020-06-080001193125-20-118928

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 18:28 ET. Listed shows no prices and gives no investment advice.